On October 26, 2020, the Food and Drug Administration (FDA) issued its long awaited final MOU which describes the conditions under which certain compounded drugs by a pharmacist in a state-licensed pharmacy, or by a licensed physician, are exempt... Read More
Community Oncology Practices & Other Dispensing Physician Practices | Integrated Delivery Network and Hospital System Pharmacy | Life Sciences | State and National Pharmacy Associations | Traditional Compounding Pharmacies (503A)

Frier Levitt Partner, Todd Mizeski, Esq. has an article featured in the current issue of Drug Topics discussing the Rutledge v. Pharmaceutical Care Management Association case that recently went before the Supreme Court (SCOTUS). The SCOTUS’s... Read More
Blogs & Articles | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | State and National Pharmacy Associations